What the biomedical community could learn from the pandemic
JOSE POZO, EUROPEAN PHOTONICS INDUSTRY CONSORTIUM
A significant problem for innovators of medical devices is how long new designs take to reach production and get into the hands of the consumers who can use them. This dilemma has become glaringly obvious as America, Europe, and the rest of the world has grappled with a disrupted supply chain during the COVID-19 pandemic.
Governmental regulation is part of the problem, requiring multiple layers of testing and approval. In both the U.S. and Europe, the groundwork must be laid to get products to clinical trial much more quickly.
But the photonics industry in the biomedical space can...Read full article
Related content from Photonics Media
Articles
Equitable and fair AI for health care requires a team effortThe potential for bias and unfairness in the integration of AI in health care-centered research and diagnostics, particularly in medical image analysis, must be addressed to ensure equitable and...
BioPhotonics Jul/Aug 2023 Issue
Targeting Chronic Disease at the Point of CareOf all chronic diseases, cardiovascular diseases are now the leading cause of death worldwide, with cancer, pulmonary diseases, and diabetes close behind. It will be important for a range of...
BioPhotonics Jul/Aug 2024 Issue
Portable photodynamic therapy could take cancer treatment worldwideMortality from cancer is on the rise in low- and middle-income countries, and the need is urgent for requisite treatment modalities that are low-cost, portable, and versatile in clinical environments...
BioPhotonics Jan/Feb 2023 Issue
Image Changing in the Surgical SuiteAs more and more surgical procedures are performed using a digital imaging view, such as robotic, laparoscopic, or thoracoscopic, and displayed on a big screen, what will the future of surgical...
BioPhotonics May/Jun 2024 Issue
Published: September 2021